149 related articles for article (PubMed ID: 21044313)
21. Inhibition of lymphoid tyrosine phosphatase by benzofuran salicylic acids.
Vang T; Xie Y; Liu WH; Vidović D; Liu Y; Wu S; Smith DH; Rinderspacher A; Chung C; Gong G; Mustelin T; Landry DW; Rickert RC; Schürer SC; Deng SX; Tautz L
J Med Chem; 2011 Jan; 54(2):562-71. PubMed ID: 21190368
[TBL] [Abstract][Full Text] [Related]
22. R620W polymorphism of protein tyrosine phosphatase PTPN22 in Egyptian children and adolescents with systemic lupus erythematosus: relation to thyroid autoimmunity.
Hamza RT; Awwad KS; Temsah KA; Hamed AI
Int J Adolesc Med Health; 2013; 25(2):143-9. PubMed ID: 23314521
[TBL] [Abstract][Full Text] [Related]
23. Fast identification of novel lymphoid tyrosine phosphatase inhibitors using target-ligand interaction-based virtual screening.
Hou X; Li R; Li K; Yu X; Sun JP; Fang H
J Med Chem; 2014 Nov; 57(22):9309-22. PubMed ID: 25372368
[TBL] [Abstract][Full Text] [Related]
24. High prevalence of protein tyrosine phosphatase non-receptor N22 gene functional variant R620W in systemic lupus erythematosus patients from Kuwait: implications for disease susceptibility.
Al-Awadhi AM; Haider MZ; Sukumaran J; Balakrishnan S
BMC Rheumatol; 2018; 2():7. PubMed ID: 30886958
[TBL] [Abstract][Full Text] [Related]
25. Lymphoid tyrosine phosphatase and autoimmunity: human genetics rediscovers tyrosine phosphatases.
Stanford SM; Mustelin TM; Bottini N
Semin Immunopathol; 2010 Jun; 32(2):127-36. PubMed ID: 20204370
[TBL] [Abstract][Full Text] [Related]
26. Protein tyrosine phosphatase PTPN22 in human autoimmunity.
Vang T; Miletic AV; Bottini N; Mustelin T
Autoimmunity; 2007 Sep; 40(6):453-61. PubMed ID: 17729039
[TBL] [Abstract][Full Text] [Related]
27. The role of PTPN22 in the pathogenesis of autoimmune diseases: A comprehensive review.
Tizaoui K; Terrazzino S; Cargnin S; Lee KH; Gauckler P; Li H; Shin JI; Kronbichler A
Semin Arthritis Rheum; 2021 Jun; 51(3):513-522. PubMed ID: 33866147
[TBL] [Abstract][Full Text] [Related]
28. Substrate specificity of lymphoid-specific tyrosine phosphatase (Lyp) and identification of Src kinase-associated protein of 55 kDa homolog (SKAP-HOM) as a Lyp substrate.
Yu X; Chen M; Zhang S; Yu ZH; Sun JP; Wang L; Liu S; Imasaki T; Takagi Y; Zhang ZY
J Biol Chem; 2011 Sep; 286(35):30526-30534. PubMed ID: 21719704
[TBL] [Abstract][Full Text] [Related]
29. The PTPN22 C1858T variant as a risk factor for rheumatoid arthritis and systemic lupus erythematosus but not for systemic sclerosis in the Colombian population.
Ramirez M; Quintana G; Diaz-Gallo LM; Caminos J; Garces M; Cepeda L; Rondon F; Restrepo JF; Egea E; Garavito G; Robledo G; Martin J; Iglesias-Gamarra A
Clin Exp Rheumatol; 2012; 30(4):520-4. PubMed ID: 22704547
[TBL] [Abstract][Full Text] [Related]
30. Role of PTPN22 in type 1 diabetes and other autoimmune diseases.
Bottini N; Vang T; Cucca F; Mustelin T
Semin Immunol; 2006 Aug; 18(4):207-13. PubMed ID: 16697661
[TBL] [Abstract][Full Text] [Related]
31. PTPN22 Variant R620W Is Associated With Reduced Toll-like Receptor 7-Induced Type I Interferon in Systemic Lupus Erythematosus.
Wang Y; Ewart D; Crabtree JN; Yamamoto A; Baechler EC; Fazeli P; Peterson EJ
Arthritis Rheumatol; 2015 Sep; 67(9):2403-14. PubMed ID: 26018863
[TBL] [Abstract][Full Text] [Related]
32. The PTPN22 R263Q polymorphism confers protection against systemic lupus erythematosus and rheumatoid arthritis, while PTPN22 R620W confers susceptibility to Graves' disease in a Mexican population.
López-Cano DJ; Cadena-Sandoval D; Beltrán-Ramírez O; Barbosa-Cobos RE; Sánchez-Muñoz F; Amezcua-Guerra LM; Juárez-Vicuña Y; Aguilera-Cartas MC; Moreno J; Bautista-Olvera J; Valencia-Pacheco G; López-Villanueva RF; Ramírez-Bello J
Inflamm Res; 2017 Sep; 66(9):775-781. PubMed ID: 28500376
[TBL] [Abstract][Full Text] [Related]
33. Cutting edge: the PTPN22 allelic variant associated with autoimmunity impairs B cell signaling.
Arechiga AF; Habib T; He Y; Zhang X; Zhang ZY; Funk A; Buckner JH
J Immunol; 2009 Mar; 182(6):3343-7. PubMed ID: 19265110
[TBL] [Abstract][Full Text] [Related]
34. PSTPIP1-LYP phosphatase interaction: structural basis and implications for autoinflammatory disorders.
Manso JA; Marcos T; Ruiz-Martín V; Casas J; Alcón P; Sánchez Crespo M; Bayón Y; de Pereda JM; Alonso A
Cell Mol Life Sci; 2022 Feb; 79(2):131. PubMed ID: 35152348
[TBL] [Abstract][Full Text] [Related]
35. The PTPN22-1858C>T (R620W) functional polymorphism is associated with generalized vitiligo in the Romanian population.
Laberge GS; Birlea SA; Fain PR; Spritz RA
Pigment Cell Melanoma Res; 2008 Apr; 21(2):206-8. PubMed ID: 18426414
[TBL] [Abstract][Full Text] [Related]
36. Exploiting novel tailored immunotherapies of type 1 diabetes: Short interfering RNA delivered by cationic liposomes enables efficient down-regulation of variant PTPN22 gene in T lymphocytes.
Pellegrino M; Ceccacci F; Petrini S; Scipioni A; De Santis S; Cappa M; Mancini G; Fierabracci A
Nanomedicine; 2019 Jun; 18():371-379. PubMed ID: 30439564
[TBL] [Abstract][Full Text] [Related]
37. The protein tyrosine phosphatase non-receptor type 22 C1858T polymorphism is a joint susceptibility locus for immunthyroiditis and autoimmune diabetes.
Dultz G; Matheis N; Dittmar M; Röhrig B; Bender K; Kahaly GJ
Thyroid; 2009 Feb; 19(2):143-8. PubMed ID: 19090780
[TBL] [Abstract][Full Text] [Related]
38. Preparation and In Vitro Evaluation of RITUXfab-Decorated Lipoplexes to Improve Delivery of siRNA Targeting C1858T PTPN22 Variant in B Lymphocytes.
Arena A; Belcastro E; Accardo A; Sandomenico A; Pagliarosi O; Rosa E; Petrini S; Conti LA; Giorda E; Corsetti T; Schiaffini R; Morelli G; Fierabracci A
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008834
[TBL] [Abstract][Full Text] [Related]
39. Protein tyrosine phosphatases in autoimmunity.
Vang T; Miletic AV; Arimura Y; Tautz L; Rickert RC; Mustelin T
Annu Rev Immunol; 2008; 26():29-55. PubMed ID: 18303998
[TBL] [Abstract][Full Text] [Related]
40. Regulation of lymphoid tyrosine phosphatase activity: inhibition of the catalytic domain by the proximal interdomain.
Liu Y; Stanford SM; Jog SP; Fiorillo E; Orrú V; Comai L; Bottini N
Biochemistry; 2009 Aug; 48(31):7525-32. PubMed ID: 19586056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
